ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
ARLZ
Delisted
ARLZ was delisted on the 20th of August, 2018.
59 hedge funds and large institutions have $29.6M invested in Aralez Pharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
-13
Holders Change %
-18.06%
% of All Funds
1.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
15
Reduced
15
Closed
16
Calls
$386K
Puts
$320K
Net Calls
+$66K
Net Calls Change
+$137K
Top Buyers
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$2.75M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$360K |
| 3 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$270K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$247K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$176K |
